We are live on ! Find out more
KCM

Kornitzer Capital Management Portfolio holdings

AUM $4.79B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+30.56%
3 Year Est. Return
+78.14%
5 Year Est. Return
+100.44%
10 Year Est. Return
+507.87%
AUM
$4.94B
AUM Growth
+$275M
Cap. Flow
-$134M
Cap. Flow %
-2.72%
Top 10 Hldgs %
16.92%
Holding
527
New
22
Increased
110
Reduced
192
Closed
28

Top Buys

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$9.95M
2
OABI icon
OmniAb
OABI
+$9.24M
3
CLFD icon
Clearfield
CLFD
+$7.38M
4
MPWR icon
Monolithic Power Systems
MPWR
+$7.32M
5
SITM icon
SiTime
SITM
+$7.29M

Sector Composition

Rank Sector Weight
1 Technology 20.04%
2 Healthcare 18.33%
3 Energy 13.38%
4 Consumer Staples 11.65%
5 Industrials 11.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPLK
226
DELISTED
Splunk Inc
SPLK
$6.43M 0.13%
74,700
-89,273
-54% -$7.21M
OABI icon
227
OmniAb
OABI
$491M
$6.34M 0.13%
+1,760,375
New +$9.24M
DKL icon
228
Delek Logistics
DKL
$3.11B
$6.33M 0.13%
140,000
ICLR icon
229
Icon
ICLR
$12.8B
$6.27M 0.13%
32,275
-23
-0.1% -$4.56K
MTDR icon
230
Matador Resources
MTDR
$6.51B
$6.22M 0.13%
+108,630
New +$6.85M
CMP icon
231
Compass Minerals
CMP
$1.13B
$6.17M 0.12%
150,508
-26,207
-15% -$1.08M
ILMN icon
232
Illumina
ILMN
$29.1B
$6.16M 0.12%
31,322
-3,550
-10% -$736K
STER
233
DELISTED
Sterling Check Corp. Common Stock
STER
$6.13M 0.12%
396,343
-72,797
-16% -$1.18M
SAM icon
234
Boston Beer
SAM
$1.85B
$6.08M 0.12%
18,458
-329
-2% -$119K
AZEK
235
DELISTED
The AZEK Co
AZEK
$6.08M 0.12%
299,030
LITE icon
236
Lumentum
LITE
$63.8B
$6.03M 0.12%
115,607
LOVE
237
LoveSac
LOVE
$258M
$6.01M 0.12%
273,172
GWRE icon
238
Guidewire Software
GWRE
$14.7B
$5.99M 0.12%
95,732
-650
-0.7% -$38.6K
GFL icon
239
GFL Environmental
GFL
$14.9B
$5.85M 0.12%
200,000
APD icon
240
Air Products & Chemicals
APD
$68.9B
$5.59M 0.11%
18,138
-72
-0.4% -$20.3K
PSX icon
241
Phillips 66
PSX
$89.5B
$5.57M 0.11%
53,551
-6,235
-10% -$638K
UBER icon
242
Uber
UBER
$160B
$5.57M 0.11%
225,178
-264,244
-54% -$7.23M
IT icon
243
Gartner
IT
$11.8B
$5.55M 0.11%
16,500
-1,000
-6% -$323K
CLF icon
244
Cleveland-Cliffs
CLF
$7.08B
$5.54M 0.11%
344,005
-29,125
-8% -$439K
ANSS
245
DELISTED
Ansys
ANSS
$5.51M 0.11%
+22,804
New +$5.31M
TXRH icon
246
Texas Roadhouse
TXRH
$13.8B
$5.4M 0.11%
59,355
DOCS icon
247
Doximity
DOCS
$4.65B
$5.36M 0.11%
159,576
TECH icon
248
Bio-Techne
TECH
$11.2B
$5.23M 0.11%
63,145
+1,077
+2% +$85.5K
HLN icon
249
Haleon
HLN
$43.7B
$5.12M 0.1%
640,541
-47,538
-7% -$323K
MELI icon
250
Mercado Libre
MELI
$98.4B
$5.08M 0.1%
6,000
-3
-0% -$2.67K

Similar funds

Kornitzer Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Kornitzer Capital Management held 527 positions worth $4.94B, up 5.9% from $4.66B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Kornitzer Capital Management's Q4 2022 filing shows 22 new, 110 increased, 192 reduced and 28 closed positions. Its largest new stake was FIVE9: 158,520 shares worth $10.8M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $18.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Energy.

  • Kornitzer Capital Management's largest Q4 2022 buy was FIVE9: 158,520 shares worth $10.8M.
  • Kornitzer Capital Management added most to Bio-Rad Laboratories Class A in Q4 2022, an estimated $6.56M increase.
  • Kornitzer Capital Management's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $18.9M.
  • Kornitzer Capital Management fully exited First Advantage in Q4 2022, selling an estimated $6.24M.
  • Kornitzer Capital Management's ten largest holdings make up 17% of its $4.94B portfolio in Q4 2022.
  • Kornitzer Capital Management opened 22 new positions and closed 28 in Q4 2022.
  • Kornitzer Capital Management's portfolio value rose 5.9% quarter-over-quarter to $4.94B.

Based on Kornitzer Capital Management's 13F filing for Q4 2022, filed 2 Feb 2023.